Comparison of insulin analogue B9AspB27Glu and soluble human insulin in insulin-treated diabetes.

Abstract

Postprandial plasma glucose excursions and plasma levels of free insulin after subcutaneous bolus injection of a rapidly absorbed monomeric insulin analogue (B9AspB27Glu) or soluble human insulin ('Actrapid HM' U100) were studied in six insulin-treated diabetic subjects. 10 U actrapid or an equimolar amount of the analogue were injected, in random order… (More)

Topics

  • Presentations referencing similar topics